149 related articles for article (PubMed ID: 37824775)
1. PATHOLOGICAL SIGNIFICANCE OF CDH1/E-CADHERIN GERMLINE SEQUENCE VARIANTS IN BREAST CANCER PATIENTS.
Tabassum S; Munir F; Al Awadh AA; Anwar Z
Exp Oncol; 2023 Oct; 45(2):170-179. PubMed ID: 37824775
[TBL] [Abstract][Full Text] [Related]
2. Genotype-first approach to identify associations between CDH1 germline variants and cancer phenotypes: a multicentre study by the European Reference Network on Genetic Tumour Risk Syndromes.
Garcia-Pelaez J; Barbosa-Matos R; Lobo S; Dias A; Garrido L; Castedo S; Sousa S; Pinheiro H; Sousa L; Monteiro R; Maqueda JJ; Fernandes S; Carneiro F; Pinto N; Lemos C; Pinto C; Teixeira MR; Aretz S; Bajalica-Lagercrantz S; Balmaña J; Blatnik A; Benusiglio PR; Blanluet M; Bours V; Brems H; Brunet J; Calistri D; Capellá G; Carrera S; Colas C; Dahan K; de Putter R; Desseignés C; Domínguez-Garrido E; Egas C; Evans DG; Feret D; Fewings E; Fitzgerald RC; Coulet F; Garcia-Barcina M; Genuardi M; Golmard L; Hackmann K; Hanson H; Holinski-Feder E; Hüneburg R; Krajc M; Lagerstedt-Robinson K; Lázaro C; Ligtenberg MJL; Martínez-Bouzas C; Merino S; Michils G; Novaković S; Patiño-García A; Ranzani GN; Schröck E; Silva I; Silveira C; Soto JL; Spier I; Steinke-Lange V; Tedaldi G; Tejada MI; Woodward ER; Tischkowitz M; Hoogerbrugge N; Oliveira C
Lancet Oncol; 2023 Jan; 24(1):91-106. PubMed ID: 36436516
[TBL] [Abstract][Full Text] [Related]
3. Associations of CDH1 germline variant location and cancer phenotype in families with hereditary diffuse gastric cancer (HDGC).
Lo W; Zhu B; Sabesan A; Wu HH; Powers A; Sorber RA; Ravichandran S; Chen I; McDuffie LA; Quadri HS; Beane JD; Calzone K; Miettinen MM; Hewitt SM; Koh C; Heller T; Wacholder S; Rudloff U
J Med Genet; 2019 Jun; 56(6):370-379. PubMed ID: 30745422
[TBL] [Abstract][Full Text] [Related]
4. Cancer predisposition and germline CTNNA1 variants.
Lobo S; Benusiglio PR; Coulet F; Boussemart L; Golmard L; Spier I; Hüneburg R; Aretz S; Colas C; Oliveira C
Eur J Med Genet; 2021 Oct; 64(10):104316. PubMed ID: 34425242
[TBL] [Abstract][Full Text] [Related]
5. The Identification of Large Rearrangements Involving Intron 2 of the
Ben Aissa-Haj J; Pinheiro H; Cornelis F; Sebai M; Meseure D; Briaux A; Berteaux P; Lefol C; Des Guetz G; Trassard M; Stevens D; Vialard F; Bieche I; Noguès C; Tang R; Oliveira C; Stoppat-Lyonnet D; Lidereau R; Rouleau E
Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553480
[TBL] [Abstract][Full Text] [Related]
6. CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype.
Corso G; Marino E; Zanzottera C; Oliveira C; Bernard L; Macis D; Figueiredo J; Pereira J; Carneiro P; Massari G; Barberis M; De Scalzi AM; Taormina SV; Sajjadi E; Sangalli C; Gandini S; D'Ecclesiis O; Trovato CM; Rotili A; Pesapane F; Nicosia L; La Vecchia C; Galimberti V; Guerini-Rocco E; Bonanni B; Veronesi P
JAMA Netw Open; 2024 Apr; 7(4):e247862. PubMed ID: 38652475
[TBL] [Abstract][Full Text] [Related]
7. Germline mutations in E-cadherin do not explain association of hereditary prostate cancer, gastric cancer and breast cancer.
Jonsson BA; Bergh A; Stattin P; Emmanuelsson M; Grönberg H
Int J Cancer; 2002 Apr; 98(6):838-43. PubMed ID: 11948460
[TBL] [Abstract][Full Text] [Related]
8. Identification and characterization of CDH1 germline variants in sporadic gastric cancer patients and in individuals at risk of gastric cancer.
Garziera M; Canzonieri V; Cannizzaro R; Geremia S; Caggiari L; De Zorzi M; Maiero S; Orzes E; Perin T; Zanussi S; De Paoli P; De Re V
PLoS One; 2013; 8(10):e77035. PubMed ID: 24204729
[TBL] [Abstract][Full Text] [Related]
9. CDH1 gene mutations do not contribute in hereditary diffuse gastric cancer in Poland.
Jakubowska A; Lawniczak M; Wojnarska B; Cybulski C; Huzarski T; Byrski T; Tołoczko-Grabarek A; Jaworska K; Durda K; Starzyńska T; Lubiński J
Fam Cancer; 2010 Dec; 9(4):605-8. PubMed ID: 20842455
[TBL] [Abstract][Full Text] [Related]
10. Association Between Hereditary Lobular Breast Cancer Due to CDH1 Variants and Gastric Cancer Risk.
Gamble LA; Rossi A; Fasaye GA; Kesserwan C; Hernandez JM; Blakely AM; Davis JL
JAMA Surg; 2022 Jan; 157(1):18-22. PubMed ID: 34643667
[TBL] [Abstract][Full Text] [Related]
11. Family's History Based on the
Caggiari L; Fornasarig M; De Zorzi M; Cannizzaro R; Steffan A; De Re V
Int J Mol Sci; 2020 Jul; 21(14):. PubMed ID: 32664545
[TBL] [Abstract][Full Text] [Related]
12. Clinical and functional characterization of the CDH1 germline variant c.1679C>G in three unrelated families with hereditary diffuse gastric cancer.
Pena-Couso L; Perea J; Melo S; Mercadillo F; Figueiredo J; Sanches JM; Sánchez-Ruiz A; Robles L; Seruca R; Urioste M
Eur J Hum Genet; 2018 Sep; 26(9):1348-1353. PubMed ID: 29769627
[TBL] [Abstract][Full Text] [Related]
13. Germline likely pathogenic variants in ataxia-telangiectasia-mutated gene in an Iranian family with hereditary diffuse gastric cancer without
Kheirollahi M; Saneipour M; Moridnia A
J Cancer Res Ther; 2021; 17(6):1434-1437. PubMed ID: 34916374
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of Hereditary Diffuse Gastric Cancer Testing Criteria and Outcomes in Patients With a Germline Mutation in CDH1.
van der Post RS; Vogelaar IP; Manders P; van der Kolk LE; Cats A; van Hest LP; Sijmons R; Aalfs CM; Ausems MG; Gómez García EB; Wagner A; Hes FJ; Arts N; Mensenkamp AR; van Krieken JH; Hoogerbrugge N; Ligtenberg MJ
Gastroenterology; 2015 Oct; 149(4):897-906.e19. PubMed ID: 26072394
[TBL] [Abstract][Full Text] [Related]
15. Clinical spectrum and pleiotropic nature of
Figueiredo J; Melo S; Carneiro P; Moreira AM; Fernandes MS; Ribeiro AS; Guilford P; Paredes J; Seruca R
J Med Genet; 2019 Apr; 56(4):199-208. PubMed ID: 30661051
[No Abstract] [Full Text] [Related]
16. Resolving pathogenicity classification for the CDH1 c.[715G>A] (p.Gly239Arg) Variant.
Yelskaya Z; Arnold AG; Marcell VJ; Tang LH; Salo-Mullen EE; Strong VE; Stadler ZK; Zhang L
Eur J Hum Genet; 2021 Jul; 29(7):1103-1109. PubMed ID: 33619332
[TBL] [Abstract][Full Text] [Related]
17. E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer.
Corso G; Pedrazzani C; Pinheiro H; Fernandes E; Marrelli D; Rinnovati A; Pascale V; Seruca R; Oliveira C; Roviello F
Eur J Cancer; 2011 Mar; 47(4):631-9. PubMed ID: 21106365
[TBL] [Abstract][Full Text] [Related]
18. Cleft lip/palate and hereditary diffuse gastric cancer: report of a family harboring a CDH1 c.687 + 1G > A germline mutation and review of the literature.
Obermair F; Rammer M; Burghofer J; Malli T; Schossig A; Wimmer K; Kranewitter W; Mayrbaeurl B; Duba HC; Webersinke G
Fam Cancer; 2019 Apr; 18(2):253-260. PubMed ID: 30306390
[TBL] [Abstract][Full Text] [Related]
19. Germline E-cadherin mutations in familial lobular breast cancer.
Masciari S; Larsson N; Senz J; Boyd N; Kaurah P; Kandel MJ; Harris LN; Pinheiro HC; Troussard A; Miron P; Tung N; Oliveira C; Collins L; Schnitt S; Garber JE; Huntsman D
J Med Genet; 2007 Nov; 44(11):726-31. PubMed ID: 17660459
[TBL] [Abstract][Full Text] [Related]
20. CDH1 germline variants are enriched in patients with colorectal cancer, gastric cancer, and breast cancer.
Adib E; El Zarif T; Nassar AH; Akl EW; Abou Alaiwi S; Mouhieddine TH; Esplin ED; Hatchell K; Nielsen SM; Rana HQ; Choueiri TK; Kwiatkowski DJ; Sonpavde G
Br J Cancer; 2022 Mar; 126(5):797-803. PubMed ID: 34949788
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
